Exelixis: Q2 Earnings Snapshot

August 9, 2022 GMT

ALAMEDA, Calif. (AP) _ Exelixis Inc. (EXEL) on Tuesday reported second-quarter net income of $70.7 million.

The Alameda, California-based company said it had profit of 22 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 20 cents per share.

The drug developer posted revenue of $419.4 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $391.1 million.

Exelixis expects full-year revenue in the range of $1.53 billion to $1.63 billion.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXEL at https://www.zacks.com/ap/EXEL